285 related articles for article (PubMed ID: 12930642)
1. [Production and purification of helper free recombinant adeno-associated virus 2].
Li GL; Wang RZ; Wang X; Dou WC; Zhang B; Tian SQ; Ren ZY; Su CB
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1255-8. PubMed ID: 12930642
[TBL] [Abstract][Full Text] [Related]
2. Optimised helper virus-free production of high-quality adeno-associated virus vectors.
Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M
J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337
[TBL] [Abstract][Full Text] [Related]
3. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
4. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
5. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.
Toublanc E; Benraiss A; Bonnin D; Blouin V; Brument N; Cartier N; Epstein AL; Moullier P; Salvetti A
J Gene Med; 2004 May; 6(5):555-64. PubMed ID: 15133766
[TBL] [Abstract][Full Text] [Related]
6. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
[TBL] [Abstract][Full Text] [Related]
7. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
8. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
9. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
10. Construction of recombinant adeno-associated virus vector containing the rat preproinsulin II gene.
Peng L; Sidner RA; Bochan MR; Burton MM; Cooper ST; Jindal RM
J Surg Res; 1997 Apr; 69(1):193-8. PubMed ID: 9202669
[TBL] [Abstract][Full Text] [Related]
11. [Gene transfer efficiencies and cell tropism of recombinant adeno-associated virus in the hippocampus of adult rat].
L i SF; Li ZJ; Li GL; Dou WC; Zhang ZX; Wei JJ; Kong YG; Xu L; Gao J; Wang RZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):512-6. PubMed ID: 16995303
[TBL] [Abstract][Full Text] [Related]
12. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
13. Establishment of effective methods for transducing genes into iris pigment epithelial cells by using adeno-associated virus type 2.
Sugano E; Tomita H; Ishiguro S; Abe T; Tamai M
Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3341-8. PubMed ID: 16123438
[TBL] [Abstract][Full Text] [Related]
14. [Construction of recombinant adeno-associated virus vector co-expressing hVEGF165 and hBMP-7 genes].
Huang X; Shi Z; Wang K; Dang X; Yang P; Yu P
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):807-13. PubMed ID: 18681280
[TBL] [Abstract][Full Text] [Related]
15. [Construction and expression of recombinant adeno-associated virus vector containing HSV1-TK gene].
Ding ZX; Tan Q; Liu SZ; Liu D; Li ZQ; Peng JQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):210-5. PubMed ID: 18382054
[TBL] [Abstract][Full Text] [Related]
16. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
Małecki M; Swoboda P; Pachecka J
Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.
Okada T; Mizukami H; Urabe M; Nomoto T; Matsushita T; Hanazono Y; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2001 Oct; 288(1):62-8. PubMed ID: 11594752
[TBL] [Abstract][Full Text] [Related]
18. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
[TBL] [Abstract][Full Text] [Related]
19. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock.
Davidoff AM; Ng CY; Sleep S; Gray J; Azam S; Zhao Y; McIntosh JH; Karimipoor M; Nathwani AC
J Virol Methods; 2004 Nov; 121(2):209-15. PubMed ID: 15381358
[TBL] [Abstract][Full Text] [Related]
20. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
